Bacterial surface structures such as type IV pili are common receptors for phage. 16 Strains of the opportunistic pathogen Pseudomonas aeruginosa express one of five 17 different major type IV pilin alleles, two of which are glycosylated with either 18 lipopolysaccharide O-antigen units or polymers of D-arabinofuranose. Here we show 19 that both these post-translational modifications protect P. aeruginosa from a variety of 20 pilus-specific phages. We identified a phage capable of infecting strains expressing both 21 non-glycosylated and glycosylated pilins, and through construction of a chimeric phage, 22
INTRODUCTION 39
Phages present a major challenge to bacterial survival in most environments 1 . 40 For this reason, bacteria have evolved a battery of anti-phage defenses including 41 CRISPR-Cas, restriction-modification, and abortive infection systems 2, 3, 4 . Such 42 strategies are effective at inhibiting diverse types of phage, but the phage genome -43 which encodes many potentially dangerous gene products -is still allowed to enter the 44 cell. The safest and most effective way to inhibit phage infection is to block it at its initial 45 step, phage particle adsorption to the cell surface. Here we describe a cell-surface 46 modification of Pseudomonas aeruginosa that can block infection by many different 47 phages. 48
Although a large number of diverse phages infecting P. aeruginosa have been 49 described, they use predominantly two cell surface receptors, lipopolysaccharides (LPS) 50
and type IV pili (T4P) 5, 6 . It is likely that the evolution of different LPS O-antigen 51 serotypes in P. aeruginosa strains has been shaped by the battle with phages, since 52 individual phage types generally infect only limited subsets of these serotypes. However, 53
it is unclear how targeting of T4P by phages has affected the evolution of their 54 components. 55 T4P are used by a wide variety of bacterial and archaeal species for adherence, 56 biofilm formation, DNA uptake, and a form of surface-associated motility called 57 'twitching' 7, 8, 9 . T4P are also virulence factors for many bacterial pathogens, including P. 58
aeruginosa 10, 11, 12, 13, 14 . Although many P. aeruginosa phages use T4P as receptors 6, 59 15, 16, 17 , the exact manner in which they interact with pili remains unknown. T4P are 60 composed of thousands of copies of the major pilin, PilA, but also contain small 61 amounts of minor (low-abundance) pilins that are thought to prime assembly by forming 62
an initiation complex to which major pilins are subsequently added, extending the pilus 63 from its base in the inner membrane 18 . Thus, minor pilins are most likely positioned at 64 the tip of assembled pili 19 , though rare incorporation along the filament may also occur 65 20 . Detailed electron microscopy studies of P. aeruginosa pilus-specific phages 66 suggested that they bind along the length of the pilus, and are pulled closer to the cell 67 surface when the pilus retracts 21 . These observations imply that the phages bind to the 68 major pilin directly, though this assumption has not been formally tested. 69
Each P. aeruginosa strain encodes one of 5 different major pilin alleles at a 70 conserved locus located between the pilB gene, encoding the pilus extension ATPase, 71
and a tRNA Thr gene 22 . The pilin variants differ with respect to their length (150 to 173 72 residues), the number of amino acids (12 to 29 residues) between the two C-terminal 73
Cys residues that form a structurally and functionally critical disulfide-bonded loop or 'D-74 region', and the presence of specific pilin accessory genes immediately downstream of 75 the pilA gene. A census of nearly 300 strains 22 revealed that the most common allele is 76 group I, a pilin that is glycosylated at the C-terminal Ser by its associated 77 glycosyltransferase, TfpO 23 . The pilin glycan is an O-antigen unit, sourced from the O-78 specific antigen (OSA, formerly B-band) lipopolysaccharide (LPS) biosynthetic pathway 79 24 . The group I allele was over-represented (close to 70%) in strains isolated from cystic 80 fibrosis patients, suggesting that it provides a significant advantage in certain 81 environments 22 . We subsequently described a second, distinct glycosylation system in 82 group IV strains, such as PA7 25, 26, 27 . The pilin subunits in this group are glycosylated 83 by their cognate glycosyltransferase TfpW on multiple Ser and Thr residues with 84 homopolymers of α1,5-linked D-arabinofuranose (D-Araf). The genes encoding the 85 biosynthesis of D-Araf polymers are unlinked to the pilin locus, but glycosylation is 86 important for stable pilin expression 26 . 87 A convincing reason for the prevalence of pilin glycosylation in nature has not yet 88 been put forward, though this modification has a modest effect on pathogenicity in mice 89 28 and decreases twitching motility on plastic 29, 30 . In Neisseria meningitidis, an obligate 90 human commensal, and in the multidrug resistant genus Acinetobacter, pilin 91 glycosylation was proposed to block binding of pilin-specific antibodies 31, 32 . Here we 92
show that modification of P. aeruginosa pilins by either of its glycosylation systems 93 blocks infection by many pilus-specific phages. We further show that phages producing 94 unique tail proteins can partially breach this defense. The ability of pilin glycosylation to 95 protect against phage predation provides a compelling rationale for the widespread 96 occurrence of this prokaryotic post-translational modification. 97
98

RESULTS
99
Pilin glycosylation blocks phage infection 100
A previous study of P. aeruginosa strain 1244, which expresses glycosylated 101 group I pilins, concluded that this post-translational modification had no effect on phage 102 susceptibility 28 . However, that study used a phage that was capable of infecting the wild 103 type strain, which expresses glycosylated pilins. While investigating the host range of a 104 large number of pilus-specific phages that we isolated previously 17 , we noted that some 105
were capable of infecting a 1244 tfpO mutant, which produces unmodified pilins, but not 106 its wild type parent. These results hinted that pilin glycosylation might represent a 107 mechanism of resistance to phages that use the pilus as a receptor. 108
Since most of the phages in our collection grow poorly on the 1244 wild type or 109 tfpO mutant strains, we performed further studies using the common laboratory strain 110 PAO1, which is sensitive to many more phages. To compare the ability of different pilA 111 alleles in a common genetic background to allow phage infection, we used a set of 112 recombinant strains expressing the pilA genes of interest from an arabinose-inducible 113 plasmid in a PAO1 pilA null mutant 29 . We then used standard phage spotting assays 17 114
to assess the ability of 19 different T4P-dependent non-contractile tailed phages to 115 replicate on strains expressing the native PAO1 PilA II (group II), or the strain 1244 PilA I 116 (group I) in the presence or absence of TfpO, which mediates pilin glycosylation. We 117 found that while all these phages plated robustly on the strains expressing PilA II or 118 unglycosylated PilA I , TfpO-mediated glycosylation of PilA I with O-antigen units 119 completely inhibited the growth of all except phage DMS3, which was partially inhibited 120
( Table 1) . 121 
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122 Most of the phages tested were similar in sequence and genome structure 17 , 123 particularly within the phage tail operon expected to be involved in host receptor binding. 124
For this reason, we focused further studies on three phages, JBD26, DMS3, and JBD68. 125 JBD26 and DMS3 are very similar in sequence and represent the dominant group in this 126 collection (P. aeruginosa phage MP22-like) while JBD68 resembles P. aeruginosa 127 phage F10 ( Supplementary Table S1 ) and its putative tail proteins display little 128 similarity to those of the other phages 17 . All three of these phages plated robustly on a 129 PAO1 pilA mutant expressing PilA I or PilA II (Fig. 1A) . However, co-expression of PilA I 130 and TfpO caused a greater than 10 5 -fold reduction of JBD26 and JBD68 infectivity, 131 while infectivity of DMS3 was reduced by ~10 3 -fold ( Fig. 1A) . To further investigate this 132 phenomenon, we mutated the C-terminal Ser of PilA I to Ala in the PilA I TfpO expressing 133 strain, precluding attachment of the glycan to the pilin 23 . The resulting strain produced 134 non-glycosylated pilins and was susceptible to all three phages ( Fig. 1A) , confirming 135 that pilin modification was responsible for resistance. 136 To ensure that changes to phage susceptibility were due to changes in pilin 146 glycosylation status, and not to differences in levels of pili on the cell surface, we 147 examined the amount of surface pili sheared from the recombinant strains. As we 148 showed previously 29 , a PAO1 pilA mutant expressing group I pilins, regardless of their 149 glycosylation status, assembled fewer surface pili compared to the strain expressing the 150 native PilA II and had reduced twitching motility (Fig. 1B) . This difference in surface 151 piliation did not affect phage susceptibility (compare pilA II versus pilA I in Fig 1A) . Since 152 the PilA I TfpO strain expressed more surface pili than the PilA I strain expressing 153 unmodified pilins, the reduction in plaquing efficiency on the former was not due to 154 inadequate piliation ( Fig. 1B) 58 and 61, while DMS3 has 3 ORFs -49-51 -at the same position ( Fig. 2A) . 167 Comparison of the amino acid sequences of the predicted gene products (gp) revealed 168 that JBD26 gp59 and DMS3 gp49 are 86% identical over the first 153 residues (shown 169 in white in Fig 2A) , but then their sequences diverge completely ( Supplementary Fig.  170  S1A) . Similarly, the last 47 residues of JBD26 gp60 and DMS3 gp51 are 96% identical, 171
while the N-termini of those proteins differ. DMS3 gp50 has no counterpart in JBD26. 172
Given the positioning of the genes encoding these proteins at the 3'-end of the tail 173 encoding regions within their respective genomes, we hypothesized that they may 174 encode tail proteins involved in host range specificity. 175 To determine if the differences in these putative tail proteins were responsible for 188 unique ability of DMS3 to infect strains with glycosylated pilins, we generated a JBD26 189 lysogen of strain PAO1, then swapped some of its tail protein genes for those of DMS3 190 via homologous recombination. Open reading frames 59 and 60 of JBD26 were 191 replaced with 49, 50 and 51 of DMS3, using the conserved flanking genes 58/48 and 192 61/52 as regions of homology for recombination ( Fig. 2A) . Strikingly, the resulting 193 JBD26/DMS3 chimeric phage infected strains expressed both non-glycosylated and 194 glycosylated pilins to the same extent as DSM3 (Fig. 2B) . These results imply that the 195 region of DMS3 encompassing ORFS 49-51 encodes the unique ability of DMS3 to use 196 the glycosylated pilus for infection. 197
198 Pilin sequence modulates phage susceptibility 199
The C-terminal Ser that is glycosylated in group I pilins is adjacent to the D-200 region of PilA 23 , suggesting that post-translational modification could mask this 201 potential phage binding surface (Fig. 3A) . To test whether phages recognize the D-202 region of PilA, we exploited a set of previously engineered PilA II single-residue 203 substitution mutants 34 . All mutants tested had similar levels of surface piliation (Fig. 3B) , 204 but plaquing assays revealed that a PilA II P138R mutant was approximately 1000-fold 205 more resistant to JBD26 and JBD68 infection than wild type, while the effect of this 206 mutation on susceptibility to DMS3 and the chimeric phage was minimal (Fig. 3C) . A 207
P138A substitution had no effect on susceptibility, while a P138M mutant had slightly 208 reduced susceptibility, implying a specific interaction between phages JBD26 and 209
JBD68 and the D-region of PilA II that is disrupted by changes in side chain electrostatics. 210
These results indicate that DMS3 and the JBD26 chimera containing DMS3 sequences 211 interact with PilA in a different manner than JBD26 and JBD68, potentially explaining 212 the ability of DMS3 to infect strains that express glycosylated subunits. 213 multiple Ser and Thr residues on PilA IV 25 . To investigate whether this form of 226 glycosylation also serves as a phage defense mechanism, we tested a set of PAO1 pilA 227 mutant strains expressing unmodified or glycosylated PilA IV . Because JBD26 does not 228 infect strains expressing PilA IV well, we turned to a closely related phage, MP22 35 . 229 MP22 gp54 has 99% identity to JBD26 gp59 that putatively recognizes unglycosylated 230 pilins, and it has a similar infection pattern (Fig. 3C) . We tested susceptibility of strains 231 expressing D-Araf glycans to MP22, JBD68, DMS3, and the chimeric phage (Fig. 4) . infection by DSM3 and the chimera, as well as MP22. Interestingly, JBD68 could not 242 infect the strain that produced unmodified PilA IV , but could infect the strain expressing 243 glycosylated PilA IV , suggesting that it recognizes a new epitope present on the modified 244 pilin, or the unique pilin glycans themselves. These data show that both of P. 245 aeruginosa's pilin glycosylation systems have the capacity to protect against subsets of 246 pilus-specific phages. In addition, phages like JBD68 appear to have evolved to exploit 247 some forms of pilin glycosylation for cell surface binding. 248
249
DISCUSSION 250
Since glycosylation of thousands of surface-exposed pilin subunits can be 251 energetically costly (each sugar requires the production of a nucleotide-activated 252 precursor, and each glycan unit contains multiple sugars), the addition of such 253 modifications must provide a valuable benefit. Here, we showed that pilin glycosylation 254 provides protection against many pilus-specific bacteriophages. Given the powerful 255 impact of phage predation on bacterial evolution, our data provide a compelling 256 rationale for the widespread glycosylation of pilins in environmental and pathogenic 257 bacteria. Glycosylation of P. aeruginosa pilins was previously suggested to protect 258 against complement binding, opsonization by pulmonary surfactant protein A, or against 259 proteolytic degradation by host or self-produced proteases 36, 37 . Similar hypotheses 260
have been advanced to explain the function of pilin glycosylation in Neisseria and 261
Acinetobacter 31, 32 . While these effects of pilus glycosylation may have some impact 262 within the context of infection, resistance to phage predation is likely of greater 263 advantage to bacteria in a much broader range of native environments and conditions. 264
A recent study of P. aeruginosa phages from cystic fibrosis sputum samples 265 suggested that phage density was ~10-100 fold greater than that of P. aeruginosa, and 266 that lytic phage activity controls bacterial numbers in chronically infected patients 38 . 267 Pilin glycosylation thus has the potential to influence virulence both directly -blocking 268 antibody and complement binding -and indirectly, allowing bacteria to make functional 269 pili and maintain high bacterial loads in the presence of pilus-specific phages. These 270 features may account for the reported prevalence (~70%) of group I strains of P. 271 aeruginosa among CF isolates 22 , as such strains are likely to be more generally 272
resistant to phage infection than strains producing non-glycosylated pili. The phage 273
protection afforded by pilin glycosylation may also explain why group I and group IV 274 pilins assemble poorly in the absence of this modification (Fig. 1) 26 . Limiting the 275 assembly of unmodified pilins may be a quality-control mechanism that reduces the 276 dangerous possibility that non-glycosylated -and thus phage-vulnerable -pili are 277 expressed on the cell surface. Although loss of pilus expression or function can also 278 protect the bacteria from phage predation, these are disadvantageous phenotypes that 279 reduce fitness 39, 40, 41 . 280 While T4P are well-established receptors for phage, the exact mode of phage 281 binding has not been clarified. Electron micrographs show binding of phage along the 282 length of pilus filaments 42 , presumably to the major pilin. Our data strongly support the 283 conclusion that phages bind directly to PilA, rather than any of the minor pilins, for the 284 following reasons: 1) Glycosylation of PilA blocks phage infection, and the minor pilins 285
are not glycosylated 18, 20, 43 . 2) The plaquing ability of all the phages tested was affected 286 by the group and/or glycosylation state of the major pilin, and all the assays were 287 performed in the PAO1 background where the minor pilins were invariant. 3) Specific 288 single amino acid substitutions in PilA changed the susceptibility of strains to phage 289 infection (Fig. 3) . Although we cannot rule out that some pilus-specific phages may bind 290 to minor pilins, the phages studied here interact with the major pilin. Given that minor 291 pilins are mainly localized to the pilus tip and are present in minute quantities relative to 292 the major pilin, the binding of phages to PilA is expected to be a superior strategy for 293 cell surface engagement. 294
The ability of the phages used in this study to use both unmodified PilA I and PilA II  295 as receptors is remarkable, as these proteins are only 25% identical outside of the 296 highly conserved N-terminal 25 residues that are largely buried in the interior of 297 assembled pilus filaments 44, 45 . The binding of phages to diverse PilA proteins likely 298 reflects the results of the evolutionary drive for phage to use a wide variety of pili as 299 receptors, and further emphasizes the difficulty of evading phage predation only through 300 accumulation of amino acid substitutions in PilA, which could also have negative 301 functional consequences. Pilus glycosylation may provide a more effective defense 302 against phages, by masking phage-binding sites through steric hindrance. Interestingly, 303 some pilus-specific phages such as JBD68 appear to have evolved the capacity to 304 recognize pilins with specific post-translational modifications (Fig. 4) , potentially 305 broadening their host range. 306
A role for DMS3 gp49, gp50 and/or gp51 in recognizing the glycosylated pilus 307 was demonstrated by recombining the genes encoding these proteins into JBD26, 308
allowing this phage to use the glycosylated group I pilus for infection. DMS3 gp49 and 309 JBD26 gp59 each have a conserved 100 residue N-terminal domain that corresponds to 310 the Pfam protein family DUF2793 (PF10983). Proteins containing this domain are 311 encoded in a variety of non-contractile tailed phage and prophage genomes, with the 312 DUF2793 protein invariably encoded immediately downstream of the gene encoding the 313 central fibre protein 46 as in JBD26 and DMS3 ( Fig. 2A) . Central fibre proteins and 314 others encoded in the 3'-regions of tail operons are often involved in host cell receptor 315
binding 46, 47 . DUF2793 proteins are variable in length and display highly divergent C-316
terminal regions. The conserved N-termini likely attach these proteins to the phage 317
particle while the C-termini may interact with the variable surfaces of host cells. Among 318 the functions predicted for the variable C-terminal domains are peptidase and glycanase 319
activities (Supplementary Fig. S1B ). This modular organization may prove useful for 320 future development of designer phages that can target specific species or strains. Mass 321 spectrometry on purified phages closely related to JBD26 and DMS3 (Supplementary 322
Table S1) confirmed that the DUF2793 proteins are present in phage particles. We 323 conclude that gp49 and gp59 are the components of DMS3 and JBD26 tails, 324 respectively, that are responsible for binding to PilA. The difference in the effects of PilA 325 mutations on infectivity of JBD26 versus DMS3 (Fig. 3C) implies that DMS3 gp49 and 326 JBD26 gp59 interact with different regions of PilA, accounting for DMS3's ability to bind 327 glycosylated PilA I , while JBD26 gp59 cannot. In contrast, the inability of DMS3 gp49 to 328 bind glycosylated PilA IV is likely due to the different position of these modifications on 329 the protein 25 . The identical plating behavior of the JBD26/DMS3 chimeric phage and 330 DMS3 implies that gp49 is responsible for conferring the unique host specificity of 331 DMS3. The functions of DMS3 gp50 and gp51 are not known, and homologues of gp51 332
were not found in phage particles ( Supplementary Table S2 ). 333
The function of type IV pilin glycosylation has long remained a mystery. We show 334
here that both of P. aeruginosa's glycosylation systems block infection by a variety of 335 pilus-specific phages, and suggest that resistance to phage attack is the major 336 evolutionary driving force for these post-translational modifications. Since pili are 337 common targets for phage adsorption in many species, pilus glycosylation may be a 338 widespread anti-phage defense system. The large size of oligosaccharide groups and 339 their typically negative charge can serve to effectively block phage accessibility to large 340 portions of the pilus surface 31 , and thus engender resistance to diverse phages. In this 341 way, glycosylation is a more broadly useful resistance mechanism than amino acid 342 substitutions in PilA, a conclusion that is supported by the ability of the phages tested 343 here to utilize PilA proteins of diverse sequence as receptors. Glycosylation also 344 provides a means to block phage infection without compromising the important adaptive 345 functions of the type IV pilus. In conclusion, pilus glycosylation is another fascinating 346 manifestation of the evolutionary battle between bacteria and phages. antibiotics and L-arabinose where indicated. After allowing the top agar to solidify, it was 369 air-dried with the lid off in a biosafety cabinet for 15 min. Phage stocks were 370 standardized to a PFU/ml of 10e8 and 10-fold serially diluted in LB plus 8 mM MgSO4, 371
and 5 µl of each dilution was spotted onto the prepared plates. After allowing the spots 372 to air dry for 10 min with lid on, the plates were incubated inverted for 18 h at 37 o C. The 373 plates were then photographed and the titre estimated as the lowest dilution generating 374 a complete zone of cell lysis. 375
Twitching motility assays 376
Twitching assays were performed as described previously 29 . Single colonies 377
were stab inoculated to the bottom of a 1% LB agar plate which was incubated for 36 h 378 at 37°C. The agar was then carefully discarded, and the adherent bacteria stained with 379 1% (w/v) crystal violet dye, followed by washing with tap water to remove unbound dye. 380
Twitching zone areas were measured using ImageJ software (NIH). All experiments 381
were performed in triplicate with at least three independent replicates. 382
Sheared surface protein preparation 383
The levels of surface-exposed pili and flagella were analyzed as described 384 previously 26 . Briefly, the strains of interest were streaked in a grid-like pattern on LB 385 agar plates and incubated at 37°C for ~16 h. The cells were scraped from the plates 386 with glass coverslips and resuspended in 4.5 mL of phosphate buffered saline, pH 7.0. 387 Surface proteins were sheared by vortexing the cell suspensions for 30 s. The 388
suspensions were transferred to three separate 1.5 mL Eppendorf tubes and cells 389 pelleted by centrifugation at 11,688 x g for 5 min. The supernatant was transferred to 390 fresh tubes and centrifuged at 11,688 x g for 20 min to pellet remaining cells. After 391 transfer of supernatants to new tubes, the surface proteins were precipitated by adding 392 1/10 volume of 5M NaCl and 30% (w/v) polyethylene glycol (PEG 8000, Sigma Aldrich) 393
to each tube and incubating on ice for 90 min. Precipitated proteins were collected by 394 centrifugation at 11,688 x g, and resuspended in 150 µL of 1X SDS sample buffer 395 (125mM Tris, pH 6.8, 2% β-mercaptoethanol, 20% glycerol, 4% SDS and 0.001% 396 bromophenol blue). Samples were boiled for 10 min and separated on 15% SDS-PAGE 397 gels. Proteins were visualized by staining with Coomassie brilliant blue. 398
Generation of a JBD26-DMS3 chimeric phage 399
To create a JBD26 chimeric phage expressing DMS3 tail protein, we first 400 generated a JBD26 lysogen of strain PAO1. The primers chimera1 5'-401 ACAAGAGAATTCCAGGATCAGTTCAATCTG-3' and chimera2 5'-402 ACAAGACTGCAGCTAGCCATTGTGCTGTAGCG-3', containing EcoRI and PstI 403 restriction sites (underlined), were used to amplify from the middle of DMS3 gp48 to the 404 end of gp52 (~3 kb). The resulting PCR product was gel-purified and ligated into the 405 suicide vector, pEX18Gm 49 . After validation of the construct by DNA sequencing, it was 406
introduced into E. coli SM10 by CaCl 2 transformation and transferred to the PAO1 407 JBD26 lysogen by biparental mating as described previously 26 . Following overnight 408 incubation at 37 o C, mating mixtures were resuspended in 1 ml LB and 100 µl was 409 plated onto Pseudomonas Isolation agar (PIA) containing 100 µg/ml of Gm to 410 counterselect the E. coli donor. Colonies were picked from PIA onto LB Gm30 agar and 411 from there, onto LB no salt, 5% sucrose agar to select against merodiploids. Colonies 412 that grew on sucrose plates were streaked in parallel on LB Gm30 and LB agar, and 413
Gm sensitive colonies were tested by colony PCR using primers DMS3gp50p1 5'-414 GAACAGAATTCGAGGTGGTTCTGATGATGATCATC-3' DMS3gp50p2 5'-415 GAACAGGATCCTCATTGCGGCAACTCCACAGG-3', designed to amplify DMS3 gp50. 416
DNA from PCR-positive colonies was reamplified using primers DMS3gp49p1 5'-417 GAACAGAATTCAGGAGGCGTATCCGCATGAGC-3' and DMS3gp52p2 5'-418 ACAAGACTGCAGCTAGCCATTGTGCTGTAGCG-3', and the resulting amplicons 419 sequenced to verify gene replacement. 420
To induce the excision of the chimeric phage, the lysogen was grown overnight in 421 LB and subcultured 1:100 to OD 600 0.6 in 3 ml of the same medium, then treated with 422 mitocycin C (final concentration 3 µg/ml) for 18 h. The remaining cells were lysed by 423 adding ~250 µl chloroform and vortexing briefly to mix. The phage were titred by 424 standard plaque assay. Ten-fold serial dilutions of the lysate were prepared and 100 µl 425 each mixed with 100 µl of PAO1 standardized to OD 600 0.3 in LB plus 10 mM MgSO 4 426 and added to 8 ml of top agar (LB plus MgSO4, 0.6% agar) that was overlaid onto a 427 standard LB plus 10 mM MgSO 4 plate and allowed to solidify. After 18h incubation at 428 37C, the dilution(s) giving countable plaques were used to calculate the plaque-forming 429 units per ml of lysate. 430 431
